Oophorectomy — How It Works, Benefits & Recovery — Procedure Guide, Recovery & Risks | MyMedicPlus

Oophorectomy is the surgical removal of one (unilateral oophorectomy) or both (bilateral oophorectomy) ovaries, performed laparoscopically (keyhole surgery through 3–4 small incisions) or via open surgery (laparotomy). It may be performed alone or combined with salpingectomy (removal of the fallopian tube on the same side — salpingo-oophorectomy), which is now routinely recommended to reduce the additional risk of fallopian tube cancer. Bilateral salpingo-oophorectomy (BSO) is often performed as part of total abdominal or laparoscopic hysterectomy for benign conditions, or as a standalone procedure for risk-reduction in genetically high-risk women. Oophorectomy is performed by gynaecologists and gynaecological oncologists, with laparoscopic technique preferred for benign indications due to faster recovery and lower morbidity. For malignant indications, the surgical approach is guided by staging requirements — open surgery provides comprehensive lymph node assessment and peritoneal inspection. The consequences of bilateral oophorectomy before natural menopause include immediate surgical menopause — elimination of oestrogen production — which carries significant implications for bone health, cardiovascular risk, cognitive function, and quality of life, requiring careful counselling and management with hormone replacement therapy in most pre-menopausal women. Bilateral oophorectomy before natural menopause — particularly before age 45 — significantly increases risks of cardiovascular disease, osteoporosis, cognitive decline, and all-cause mortality compared to women who retain ovaries until natural menopause. These risks are attenuated by hormone replacement therapy, which is recommended for most pre-menopausal women undergoing bilateral oophorectomy unless contraindicated by personal or family history of hormone-sensitive cancers.

Oophorectomy is indicated for several distinct clinical scenarios. Ovarian malignancy: primary ovarian cancer (epithelial, germ cell, sex-cord stromal types) requires bilateral salpingo-oophorectomy with comprehensive surgical staging. Borderline ovarian tumours may allow fertility-sparing unilateral approach in young women with stage IA disease. Ovarian cysts: complex cysts with suspicious features (solid component, internal septations, elevated CA-125, bilateral) require surgical excision with histological examination. Simple cysts under 7 cm that persist beyond 3 months may be managed conservatively in pre-menopausal women. Endometriosis: severe ovarian endometriosis (endometrioma) causing pain and recurrent cysts after medical therapy and repeated cystectomy may eventually require oophorectomy. Ovarian torsion: if the ovary is non-viable after untwisting, oophorectomy is performed. Risk-reducing prophylactic BSO: BRCA1 carriers have a 40–59% lifetime risk of ovarian cancer; BRCA2 carriers, 10–25%. ACOG and NCCN guidelines recommend risk-reducing bilateral salpingo-oophorectomy (RRBSO) at age 35–40 (BRCA1) or 40–45 (BRCA2) after completion of child-bearing. This reduces ovarian cancer risk by over 96% and reduces breast cancer risk by 50% (BRCA1) when performed before natural menopause. Lynch syndrome patients (MSH2, MLH1 mutations) also have elevated gynaecological cancer risk warranting surveillance and consideration of prophylactic surgery.

Under general anaesthesia, laparoscopic oophorectomy begins with CO2 insufflation creating pneumoperitoneum, then trocar placement (one 10–12 mm umbilical port and two 5 mm working ports). A 30-degree laparoscope provides magnified high-definition visualisation of the pelvis. The infundibulopelvic ligament — containing the ovarian vessels (ovarian artery and vein) — is identified, skeletonised, and divided using bipolar energy forceps (LigaSure or similar) or clips with scissors. The utero-ovarian ligament connecting the ovary to the uterus is divided similarly, completely mobilising the ovary. The fallopian tube is included if salpingo-oophorectomy is planned (the mesosalpinx is divided). The adnexal specimen is placed in an impermeable retrieval bag before removal through an extended port site to prevent intraperitoneal spillage (critical for suspected malignancy — rupture of a malignant cyst worsens staging). For large ovaries or cysts, the bag is delivered through a small Pfannenstiel (bikini-line) incision. Frozen section histological examination may be requested intraoperatively if the diagnosis is uncertain, to guide the extent of surgery. Haemostasis is confirmed with irrigation of the pelvic peritoneum. For open surgery (laparotomy), a Pfannenstiel or midline incision provides access for large masses or staging requirements. Operative time is 45–90 minutes for uncomplicated laparoscopic unilateral oophorectomy, longer for bilateral or complex procedures.

The benefits of oophorectomy are substantial in the appropriate clinical context. For benign conditions, laparoscopic oophorectomy resolves recurrent ovarian cysts, ovarian endometrioma pain, and ovarian torsion definitively with a complication rate under 3% and rapid recovery. Prophylactic bilateral salpingo-oophorectomy in BRCA1 and BRCA2 carriers is one of the most powerful cancer prevention strategies available: RRBSO reduces ovarian cancer risk by over 96%, reduces breast cancer incidence by 50% in BRCA1 carriers when performed before natural menopause (per NEJM 2002 and multiple subsequent studies), and reduces breast cancer-specific mortality. The Cancer Genetics Studies Consortium estimates that RRBSO in BRCA1 carriers reduces overall cancer mortality by 75%. Laparoscopic oophorectomy allows hospital discharge at 1–2 days with return to normal activities in 2–3 weeks — significantly superior to open surgery recovery. For ovarian cancer, thorough laparotomy with maximal cytoreduction (complete surgical removal of all visible tumour) combined with platinum-based chemotherapy achieves 5-year survival of 87% for stage I disease. In India, laparoscopic oophorectomy costs approximately INR 40,000–80,000 (USD 500–1,000), compared to USD 8,000–20,000 in the USA.

Surgical risks of laparoscopic oophorectomy include haemorrhage from ovarian vessels (requiring vessel clip reinforcement or bipolar coagulation), bladder injury (0.3–0.5%), ureteral injury (0.2–0.5% — particularly relevant when operating in dense endometriotic adhesions), bowel injury, port-site hernia, wound infection, and port-site bleeding. Intraoperative conversion to open surgery occurs in under 5% for benign disease due to dense adhesions or haemostasis issues. Cyst rupture during extraction increases risk of peritoneal seeding for borderline tumours — impermeable retrieval bags significantly reduce this risk. The most significant and unavoidable consequence of bilateral oophorectomy in pre-menopausal women is surgical menopause: immediate cessation of ovarian oestrogen and progesterone production causes acute vasomotor symptoms (hot flushes, night sweats), urogenital atrophy, sexual dysfunction, mood changes, sleep disruption, and accelerated bone loss (osteoporosis). Long-term consequences of untreated surgical menopause include significantly increased cardiovascular risk, increased mortality (all-cause and cardiovascular), and cognitive decline. Hormone replacement therapy (combined oestrogen-progestogen if uterus present; oestrogen-only post-hysterectomy) is recommended for all women with surgical menopause before age 51 to mitigate these risks, continued until the average age of natural menopause.

Following laparoscopic oophorectomy, most patients are discharged within 24–48 hours. Pain from the procedure is typically mild-to-moderate: regular paracetamol and ibuprofen manage most patients; tramadol or codeine is prescribed for breakthrough pain in the first 2–3 days. Shoulder-tip pain from residual CO2 diaphragm irritation resolves within 24–48 hours. Light activities are permitted from day 1; return to desk work at 1–2 weeks; strenuous exercise and heavy lifting after 3–4 weeks for laparoscopic; 6 weeks for open surgery. Vaginal rest is not required after isolated oophorectomy (only if combined with hysterectomy). Wound care involves Steri-strips or absorbable sutures — shower permitted at 48 hours. For women undergoing RRBSO, immediate post-operative HRT counselling and prescription is arranged before discharge to prevent acute menopausal symptoms. Hormone therapy options (transdermal oestradiol patch, oestrogen-only for women without uterus) and their benefits, risks, and monitoring are discussed at the follow-up appointment at 4–6 weeks. Bone density DEXA scan at baseline and at 2 years post-RRBSO monitors for bone loss. Annual mammography and breast MRI surveillance is intensified after RRBSO in BRCA carriers. Histopathological results from the excised specimen are reviewed at the follow-up appointment.